Elevai Financial Statements From 2010 to 2026

ELAB Stock   5.25  0.32  5.75%   
Elevai Labs' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Elevai Labs' valuation are provided below:
Gross Profit
-234.5 K
Market Capitalization
2.8 M
Enterprise Value Revenue
2.5884
Revenue
285.9 K
Earnings Share
151.07
We have found one hundred twenty available fundamental signals for Elevai Labs Common, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Elevai Labs Common prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Elevai Labs Total Revenue

2.98 Million

Check Elevai Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevai Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 52.1 K, Selling General Administrative of 615.3 K or Selling And Marketing Expenses of 260.3 K, as well as many indicators such as Price To Sales Ratio of 0.14, Dividend Yield of 0.0 or PTB Ratio of 0.0453. Elevai financial statements analysis is a perfect complement when working with Elevai Labs Valuation or Volatility modules.
  
Build AI portfolio with Elevai Stock
Check out the analysis of Elevai Labs Correlation against competitors.

Elevai Labs Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets10.9 M10.3 M2.2 M
Slightly volatile
Short and Long Term Debt Total189.8 K242.1 K99 K
Slightly volatile
Other Current Liabilities1.6 M1.5 M317 K
Slightly volatile
Total Current Liabilities2.2 M2.1 M505.2 K
Slightly volatile
Accounts Payable305 K553.1 K132.1 K
Slightly volatile
Cash4.8 M4.6 M1.1 M
Slightly volatile
Cash And Short Term Investments4.8 M4.6 M1.1 M
Slightly volatile
Common Stock Shares Outstanding4.9 K5.1 K1.8 M
Slightly volatile
Liabilities And Stockholders Equity10.9 M10.3 M2.2 M
Slightly volatile
Other Current Assets2.5 M2.4 M484.3 K
Slightly volatile
Other Stockholder Equity24.1 M22.9 MM
Slightly volatile
Total Liabilities2.8 M2.7 M624.8 K
Slightly volatile
Total Current Assets7.3 MM1.6 M
Slightly volatile
Short Term Debt143.1 K166.8 K76.8 K
Slightly volatile
Common Stock37.6239.6770
Slightly volatile
Property Plant And Equipment Net92997855.9 K
Pretty Stable
Non Current Assets Total3.6 M3.4 M638 K
Slightly volatile
Net Receivables5.8 K6.1 K5.1 K
Slightly volatile
Inventory893940156.4 K
Pretty Stable
Net Invested CapitalM7.7 M1.9 M
Slightly volatile
Property Plant And Equipment Gross2.2 K2.3 K59.7 K
Pretty Stable
Capital Stock37.6239.61.1 K
Slightly volatile
Net Working Capital2.5 M4.9 M1.3 M
Slightly volatile
Current Deferred Revenue25.8 K42.2 K16.1 K
Slightly volatile
Non Currrent Assets Other169.3 K161.2 K36.6 K
Slightly volatile
Other Assets0.80.90.9824
Slightly volatile
Intangible Assets2.2 M2.5 M2.8 M
Slightly volatile

Elevai Labs Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization52.1 K74.8 K157.1 K
Slightly volatile
Selling General Administrative615.3 K647.7 K493.4 K
Slightly volatile
Selling And Marketing Expenses260.3 K336.4 K108.3 K
Slightly volatile
Other Operating Expenses2.9 MM1.4 M
Slightly volatile
Research Development220.5 K120.4 K148.9 K
Slightly volatile
Total Operating Expenses2.6 M4.2 M1.2 M
Slightly volatile
Total RevenueM2.8 M633.7 K
Slightly volatile
Cost Of Revenue431.8 K770.7 K164.9 K
Slightly volatile
Reconciled Depreciation9.3 K14.9 K5.2 K
Slightly volatile

Elevai Labs Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change In Cash878 K756.2 K342.4 K
Slightly volatile
Total Cash From Financing Activities8.2 M7.8 M2.1 M
Slightly volatile
End Period Cash Flow4.8 M4.6 M1.1 M
Slightly volatile
Stock Based Compensation106.2 K111.7 K157.8 K
Pretty Stable
Begin Period Cash FlowM3.8 M758.6 K
Slightly volatile
Depreciation9.3 K14.9 K5.2 K
Slightly volatile
Issuance Of Capital Stock4.9 MM2.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.140.159.6 M
Slightly volatile
Days Sales Outstanding0.850.9534
Slightly volatile
Average Payables509 K484.7 K157.7 K
Slightly volatile
Stock Based Compensation To Revenue0.0430.0453122
Slightly volatile
Capex To Depreciation0.770.818.8284
Slightly volatile
Inventory Turnover607578108
Slightly volatile
Days Of Inventory On Hand0.620.6514.6 K
Slightly volatile
Payables Turnover0.781.250.3679
Slightly volatile
Sales General And Administrative To Revenue0.250.26515
Slightly volatile
Average Inventory131.5 K223.5 K121.5 K
Slightly volatile
Research And Ddevelopement To Revenue0.04630.0488106
Slightly volatile
Capex To Revenue0.00410.004327.7287
Slightly volatile
Cash Per Share1.1 K631499
Slightly volatile
Days Payables Outstanding286301K
Slightly volatile
Income Quality0.740.790.9357
Slightly volatile
Intangibles To Total Assets0.250.280.3061
Slightly volatile
Current Ratio2.13.031.3226
Slightly volatile
Receivables Turnover44242184.8961
Slightly volatile
Capex Per Share1.381.451.4995
Slightly volatile
Average Receivables12.3 K18.6 K6.7 K
Slightly volatile
Revenue Per Share712391274
Slightly volatile
Interest Debt Per Share11011645.681
Slightly volatile
Debt To Assets0.04430.04660.94
Slightly volatile
Operating Cycle1.471.5515.1 K
Slightly volatile
Days Of Payables Outstanding286301K
Slightly volatile
Ebt Per Ebit1.011.941.1356
Slightly volatile
Total Debt To Capitalization0.0570.0637.821
Slightly volatile
Quick Ratio1.863.031.2191
Slightly volatile
Net Income Per E B T1.241.41.5273
Slightly volatile
Cash Ratio1.441.990.9234
Slightly volatile
Days Of Inventory Outstanding0.620.6514.6 K
Slightly volatile
Days Of Sales Outstanding0.850.9534
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.151.0522
Pretty Stable
Fixed Asset Turnover2.1 KK380
Slightly volatile
Debt Ratio0.04430.04660.94
Slightly volatile
Price Sales Ratio0.140.159.6 M
Slightly volatile
Asset Turnover0.20.250.0867
Slightly volatile

Elevai Labs Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap348.5 K366.8 K4.1 M
Slightly volatile

Elevai Fundamental Market Drivers

Elevai Upcoming Events

11th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Elevai Labs Financial Statements

Elevai Labs stakeholders use historical fundamental indicators, such as Elevai Labs' revenue or net income, to determine how well the company is positioned to perform in the future. Although Elevai Labs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Elevai Labs' assets and liabilities are reflected in the revenues and expenses on Elevai Labs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Elevai Labs Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue42.2 K25.8 K
Total Revenue2.8 MM
Cost Of Revenue770.7 K431.8 K
Stock Based Compensation To Revenue 0.05  0.04 
Sales General And Administrative To Revenue 0.26  0.25 
Research And Ddevelopement To Revenue 0.05  0.05 
Revenue Per Share 390.60  712.06 
Ebit Per Revenue(0.68)(0.71)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Elevai Labs Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elevai Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elevai Labs Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elevai Labs Common Stock:
Check out the analysis of Elevai Labs Correlation against competitors.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs. If investors know Elevai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevai Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
151.07
Revenue Per Share
4.075
Quarterly Revenue Growth
(0.46)
Return On Assets
(0.28)
Return On Equity
(0.76)
The market value of Elevai Labs Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs' value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs' market value can be influenced by many factors that don't directly affect Elevai Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevai Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevai Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevai Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.